Home Alzheimer’s Disease FDA Approves Ripretinib Tablets for Advanced Gastrointestinal Stromal Tumor

FDA Approves Ripretinib Tablets for Advanced Gastrointestinal Stromal Tumor

The FDA approved ripretinib (Qinlock) tablets as the first new drug specifically approved as a fourth-line treatment for advanced gastrointestinal stromal tumor (GIST).

Ripretinib is now indicated for adult patients who have received prior treatment with 3 or more kinase inhibitor therapies, including imatinib (Gleevec).

“Despite the progress that has been made over the past 20 years in developing treatments for GIST, including 4 FDA-approved targeted therapies — imatinib in 2002, sunitinib (Sutent) in 2006, regorafenib (Stivarga) in 2013, and avapritinib (Ayvakit) earlier this year — some patients don’t respond to treatment and their tumors continues to progress,” Richard Padzur, MD, director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research, said in a press…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Cause of Alzheimer’s disease traced to mutation in common enzyme

submitted by /u/scotsman81 Continue Reading to the Source

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Recent Comments